scholarly article | Q13442814 |
P2093 | author name string | Michael S Radin | |
P2860 | cites work | Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis | Q46743392 |
Glycosylated hemoglobins in normal pregnancy: sequential changes and relation to birth weight | Q47247409 | ||
Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level | Q47357190 | ||
Red cell transfusion decreases hemoglobin A1c in patients with diabetes. | Q50555635 | ||
Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentration. | Q50855140 | ||
[Homeostasis of blood glucose and abuse of exogenous opiates: evaluation of fructosamine and glycosylated hemoglobin]. | Q52267762 | ||
Elevation of the hemoglobin A1 fraction in alcoholism | Q70251228 | ||
Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia | Q70392123 | ||
Biphasic changes in hemoglobin A1c concentrations during normal human pregnancy | Q70996693 | ||
Iron deficiency and glycosylated haemoglobin A | Q72428467 | ||
Evaluation of HbA1c determination methods in patients with hemoglobinopathies | Q73928828 | ||
Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus | Q78145776 | ||
Delay in diagnosis of diabetes mellitus due to inaccurate use of hemoglobin A1C levels | Q79494656 | ||
Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection | Q79700757 | ||
Difficulties in interpreting HbA(1c) results | Q84120811 | ||
Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria | Q84932970 | ||
Diagnosis and Classification of Diabetes Mellitus | Q22255454 | ||
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | Q24642456 | ||
Translating the A1C assay into estimated average glucose values | Q24655833 | ||
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? | Q28334713 | ||
Red blood cell survival and kinetics during pregnancy | Q34080423 | ||
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. | Q34131682 | ||
Fructosamine: structure, analysis, and clinical usefulness. | Q34174054 | ||
Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay | Q34336230 | ||
Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit. | Q34420026 | ||
A1C versus glucose testing: a comparison. | Q34507349 | ||
1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions | Q34726941 | ||
The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo | Q35202084 | ||
The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring | Q35349795 | ||
Tests of glycemia in diabetes | Q35818970 | ||
Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes | Q35869552 | ||
Measurement of hemoglobin A(1c): a new twist on the path to harmony | Q36426683 | ||
A review of variant hemoglobins interfering with hemoglobin A1c measurement | Q37404436 | ||
The clinical use of hemoglobin A1c. | Q37404553 | ||
HbA1c and factors other than diabetes mellitus affecting it | Q37789633 | ||
Technologies for continuous glucose monitoring: current problems and future promises | Q37815571 | ||
Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care | Q37819512 | ||
Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis | Q37849073 | ||
Effect of normal pregnancy upon the glycosylated haemoglobins | Q40705780 | ||
Effect of Vitamin C on Glycosylation of Proteins | Q42105876 | ||
Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c. | Q42598246 | ||
Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4. | Q43142843 | ||
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis | Q43199808 | ||
GlucoMen Day continuous glucose monitoring system: a screening for enzymatic and electrochemical interferents | Q43248908 | ||
Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. | Q43605435 | ||
Long-term glycemic control measurements in diabetic patients receiving hemodialysis | Q43882848 | ||
Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients | Q45043007 | ||
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline | Q46114434 | ||
Falsely low hemoglobin A1c levels in a patient receiving ribavirin and peginterferon alfa-2b for hepatitis C. | Q46180646 | ||
P433 | issue | 2 | |
P304 | page(s) | 388-394 | |
P577 | publication date | 2013-09-04 | |
P1433 | published in | Journal of General Internal Medicine | Q6295242 |
P1476 | title | Pitfalls in hemoglobin A1c measurement: when results may be misleading | |
P478 | volume | 29 |